Advertisement
Screener

MusclePharm Corporation Interest Expense

MusclePharm Corporation Interest Expense

MusclePharm Corporation reported Interest Expense of $3.82 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2022-05-16

  • MusclePharm Corporation interest expense for the quarter ending 2022-03-31 was $3.82M, a 649.22% increase year-over-year.
  • MusclePharm Corporation interest expense for the quarter ending 2021-06-30 was $501.00K, a 7.90% decline year-over-year.
  • MusclePharm Corporation interest expense for the quarter ending 2021-03-31 was $510.00K, a 13.41% decline year-over-year.
  • MusclePharm Corporation interest expense for the quarter ending 2020-12-31 was -$46.00K, a 107.64% decline year-over-year.
  • MusclePharm Corporation interest expense for fiscal 2021 was $5.46M, a 265.71% increase from fiscal 2020.
  • MusclePharm Corporation interest expense for fiscal 2020 was $1.49M, a 58.63% decline from fiscal 2019.
  • MusclePharm Corporation interest expense for fiscal 2019 was $3.61M, a 7.39% decline from fiscal 2018.
  • MusclePharm Corporation interest expense for fiscal 2018 was $3.90M, a 1.46% increase from fiscal 2017.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 monthInterest Expense 12 month as first filed
2022-03-31$3.82M
10-Q · filed 2022-05-16
2021-12-31$5.46M
10-K/A · filed 2022-05-04
2021-06-30$501.00K
10-Q · filed 2021-08-16
$680.00K
10-Q · filed 2021-08-16
$965.00K
derived: sum of 3 quarters · filed 2022-05-16
$1.42M
derived: sum of 4 quarters · filed 2022-05-16
2021-03-31$510.00K
10-Q · filed 2022-05-16
$178.00K
10-Q · filed 2021-05-24
$464.00K
derived: sum of 2 quarters · filed 2022-05-16
$920.00K
derived: sum of 3 quarters · filed 2022-05-16
$1.46M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$46.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-04
$410.00K
derived: sum of 2 quarters · filed 2022-05-04
$954.00K
derived: sum of 3 quarters · filed 2022-05-04
$1.49M
10-K/A · filed 2022-05-04
$1.03M
10-K · filed 2021-03-29
2020-09-30$456.00K
10-Q · filed 2020-11-24
$1.00M
derived: sum of 2 quarters · filed 2021-08-16
$1.54M
10-Q · filed 2020-11-24
$2.19M
derived: sum of 4 quarters · filed 2021-08-16
2020-06-30$544.00K
10-Q · filed 2021-08-16
$1.08M
10-Q · filed 2021-08-16
$1.74M
derived: sum of 3 quarters · filed 2021-08-16
$2.66M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$589.00K
10-Q · filed 2021-05-24
$539.00K
10-Q · filed 2020-11-24
$1.19M
derived: sum of 2 quarters · filed 2021-05-24
$2.11M
derived: sum of 3 quarters · filed 2021-05-24
$3.03M
derived: sum of 4 quarters · filed 2021-05-24
2019-12-31$602.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29
$1.52M
derived: sum of 2 quarters · filed 2021-03-29
$2.44M
derived: sum of 3 quarters · filed 2021-03-29
$3.61M
10-K · filed 2021-03-29
2019-09-30$923.00K
10-Q · filed 2020-11-24
$1.84M
derived: sum of 2 quarters · filed 2020-11-24
$3.01M
10-Q · filed 2020-11-24
$3.95M
derived: sum of 4 quarters · filed 2020-11-24
2019-06-30$919.00K
10-Q · filed 2020-11-24
$2.08M
10-Q · filed 2020-11-24
$3.03M
derived: sum of 3 quarters · filed 2020-11-24
$3.88M
derived: sum of 4 quarters · filed 2020-11-24
2019-03-31$1.17M
10-Q · filed 2020-11-24
$2.11M
derived: sum of 2 quarters · filed 2020-11-24
$2.96M
derived: sum of 3 quarters · filed 2020-11-24
$3.98M
derived: sum of 4 quarters · filed 2020-11-24
2018-12-31$945.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-25
$1.79M
derived: sum of 2 quarters · filed 2020-08-25
$2.82M
derived: sum of 3 quarters · filed 2020-08-25
$3.90M
10-K · filed 2020-08-25
2018-09-30$850.00K
10-Q · filed 2020-08-25
$1.88M
derived: sum of 2 quarters · filed 2020-08-25
$2.95M
10-Q · filed 2020-08-25
2018-06-30$1.02M
10-Q · filed 2020-08-25
$2.10M
10-Q · filed 2020-08-25
2018-03-31$1.08M
10-Q · filed 2020-08-25
2017-12-31$3.84M
10-K · filed 2020-08-25
2011-09-30-$499.80K
10-Q/A · filed 2012-07-09
$2.48M
derived: sum of 2 quarters · filed 2012-07-13
$3.00M
10-Q/A · filed 2012-07-09
2011-06-30$2.98M
10-Q/A · filed 2012-07-13
$3.50M
10-Q/A · filed 2012-07-13
2010-12-31-$420.30K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2011-09-27
-$188.56K
derived: sum of 2 quarters · filed 2012-07-09
$127.72K
derived: sum of 3 quarters · filed 2012-07-13
$480.59K
10-K/A · filed 2011-09-27
2010-09-30$231.74K
10-Q/A · filed 2012-07-09
$548.02K
derived: sum of 2 quarters · filed 2012-07-13
$900.89K
10-Q/A · filed 2012-07-09
2010-06-30$316.28K
10-Q/A · filed 2012-07-13
$674.34K
10-Q/A · filed 2012-07-13
2009-12-31$102.39K
10-K/A · filed 2011-09-27